Getting a new drugmaking technology through clinical development and to market is a major milestone, the culmination of years of scientific work. But the true test of how important that technology is comes afterwards, when the real world gets its hands on it.
This type of story is playing out either right now, or soon will, in biopharma for multiple new forms of cutting edge medicine. Gene therapy, and CAR-T cell therapy, two genetic modification techniques that promise long-lasting results with a single treatment, are in the early days of their commercial launch in the U.S. Another drugmaking method, RNA interference,… Read more »
UNDERWRITERS AND PARTNERS